IMMUNOAFFINITY PURIFICATION OF RECOMBINANT HEPATITIS-B SURFACE-ANTIGEN FROM YEAST USING A MONOCLONAL-ANTIBODY

被引:50
作者
AGRAZ, A
DUARTE, CA
COSTA, L
PEREZ, L
PAEZ, R
PUJOL, V
FONTIRROCHI, G
机构
[1] CTR GENET ENGN & BIOTECHNOL,DIV IMMUNOTECHNOL,HAVANA,CUBA
[2] CTR GENET ENGN & BIOTECHNOL,DEPT QUAL CONTROL,HAVANA,CUBA
[3] CTR GENET ENGN & BIOTECHNOL,HEPATITIS B VACCINE PROD UNIT,HAVANA,CUBA
[4] CTR GENET ENGN & BIOTECHNOL,CAMAGUEY,CUBA
关键词
D O I
10.1016/0021-9673(94)80591-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A murine monoclonal antibody developed for the purification of recombinant hepatitis B surface antigen was immobilized on a chromatographic support and used to adsorb and purify the recombinant antigen from yeast. The adsorption-elution behaviour was first investigated using monoclonal antibody-coated enzyme-linked immunosorbent assay plates and performing adsorption, washing and elution procedures with different elution agents. It was found that 3 M KSCN and 8 M urea at neutral pH disrupted antigen-antibody interactions in both systems. The procedure for washing the immunoaffinity column was optimized, using different salts and detergents. The best results were obtained by applying the starting material in 1 M NaCl and washing with the same buffer. The use of 0.1% sodium deoxycholate in the washing buffer reduced about 20-fold lipopolysaccharide contamination in the eluates as compared with washing without detergent. The relationship between bed height and the adsorption capacity of the column was studied, and it was found that the dynamic capacity decreased twice on reducing its length/diameter ratio tenfold. The recovery of antigen was not affected by increasing the flow-rate up to 25 cm/h but decreased at higher values. Using the optimum conditions, the affinity column was able to purify the recombinant hepatitis B surface antigen to more than 90% purity and a 65% antigen recovery was obtained.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 26 条
  • [1] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [2] EXPRESSION IN ESCHERICHIA-COLI OF HEPATITIS-B VIRUS-DNA SEQUENCES CLONED IN PLASMID-PBR322
    BURRELL, CJ
    MACKAY, P
    GREENAWAY, PJ
    HOFSCHNEIDER, PH
    MURRAY, K
    [J]. NATURE, 1979, 279 (5708) : 43 - 47
  • [3] AMPLIFICATION OF EXPRESSION OF HEPATITIS-B SURFACE-ANTIGEN IN 3T3 CELLS COTRANSFECTED WITH A DOMINANT-ACTING GENE AND CLONED VIRAL-DNA
    CHRISTMAN, JK
    GERBER, M
    PRICE, PM
    FLORDELLIS, C
    EDELMAN, J
    ACS, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (06): : 1815 - 1819
  • [4] CRAIG WS, 1989, Patent No. 106753
  • [5] HIGH-LEVEL EXPRESSION AND EFFICIENT ASSEMBLY OF HEPATITIS-B SURFACE-ANTIGEN IN THE METHYLOTROPHIC YEAST, PICHIA-PASTORIS
    CREGG, JM
    TSCHOPP, JF
    STILLMAN, C
    SIEGEL, R
    AKONG, M
    CRAIG, WS
    BUCKHOLZ, RG
    MADDEN, KR
    KELLARIS, PA
    DAVIS, GR
    SMILEY, BL
    CRUZE, J
    TORREGROSSA, R
    VELICELEBI, G
    THILL, GP
    [J]. BIO-TECHNOLOGY, 1987, 5 (05): : 479 - 485
  • [6] SYNTHESIS OF HEPATITIS-B SURFACE AND CORE ANTIGENS IN ESCHERICHIA-COLI
    EDMAN, JC
    HALLEWELL, RA
    VALENZUELA, P
    GOODMAN, HM
    RUTTER, WJ
    [J]. NATURE, 1981, 291 (5815) : 503 - 506
  • [7] PRODUCTION AND IMMUNOLOGICAL ANALYSIS OF RECOMBINANT HEPATITIS-B VACCINE
    EMINI, EA
    ELLIS, RW
    MILLER, WJ
    MCALEER, WJ
    SCOLNICK, EM
    GERETY, RJ
    [J]. JOURNAL OF INFECTION, 1986, 13 : 3 - &
  • [8] Fontirrochi Giuvel, 1993, Biotecnologia Aplicada, V10, P24
  • [9] HEPATITIS-B SURFACE-ANTIGEN - ROLE OF LIPIDS IN MAINTAINING THE STRUCTURAL AND ANTIGENIC PROPERTIES OF PROTEIN-COMPONENTS
    GAVILANES, F
    GOMEZGUTIERREZ, J
    ARACIL, M
    GONZALEZROS, JM
    FERRAGUT, JA
    GUERRERO, E
    PETERSON, DL
    [J]. BIOCHEMICAL JOURNAL, 1990, 265 (03) : 857 - 864
  • [10] HAMADA F, 1988, Patent No. 4738926